These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). Hamuro Y, Anand GS, Kim JS, Juliano C, Stranz DD, Taylor SS, Woods VL. J Mol Biol; 2004 Jul 23; 340(5):1185-96. PubMed ID: 15236976 [Abstract] [Full Text] [Related]
8. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting. Yu S, Mei FC, Lee JC, Cheng X. Biochemistry; 2004 Feb 24; 43(7):1908-20. PubMed ID: 14967031 [Abstract] [Full Text] [Related]
9. Dynamic binding of PKA regulatory subunit RI alpha. Gullingsrud J, Kim C, Taylor SS, McCammon JA. Structure; 2006 Jan 24; 14(1):141-9. PubMed ID: 16407073 [Abstract] [Full Text] [Related]
10. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. Herberg FW, Maleszka A, Eide T, Vossebein L, Tasken K. J Mol Biol; 2000 Apr 28; 298(2):329-39. PubMed ID: 10764601 [Abstract] [Full Text] [Related]
11. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase. Herberg FW, Taylor SS, Dostmann WR. Biochemistry; 1996 Mar 05; 35(9):2934-42. PubMed ID: 8608131 [Abstract] [Full Text] [Related]
12. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Nesterova MV, Cho-Chung YS. Clin Cancer Res; 2004 Jul 01; 10(13):4568-77. PubMed ID: 15240549 [Abstract] [Full Text] [Related]
13. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA. Burns LL, Canaves JM, Pennypacker JK, Blumenthal DK, Taylor SS. Biochemistry; 2003 May 20; 42(19):5754-63. PubMed ID: 12741833 [Abstract] [Full Text] [Related]
14. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics. Anand G, Taylor SS, Johnson DA. Biochemistry; 2007 Aug 14; 46(32):9283-91. PubMed ID: 17658893 [Abstract] [Full Text] [Related]
15. Dynamic unfolding of a regulatory subunit of cAMP-dependent protein kinase by capillary electrophoresis: Impact of cAMP dissociation on protein stability. Gavina JM, Das R, Britz-McKibbin P. Electrophoresis; 2006 Nov 14; 27(21):4196-204. PubMed ID: 17024688 [Abstract] [Full Text] [Related]
16. Differential effects of substrate on type I and type II PKA holoenzyme dissociation. Vigil D, Blumenthal DK, Brown S, Taylor SS, Trewhella J. Biochemistry; 2004 May 18; 43(19):5629-36. PubMed ID: 15134437 [Abstract] [Full Text] [Related]
19. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis. Nesterova MV, Cho-Chung YS. Ann N Y Acad Sci; 2005 Nov 18; 1058():255-64. PubMed ID: 16394142 [Abstract] [Full Text] [Related]
20. Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Yokozaki H, Tortora G, Pepe S, Maronde E, Genieser HG, Jastorff B, Cho-Chung YS. Cancer Res; 1992 May 01; 52(9):2504-8. PubMed ID: 1314695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]